These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 31481162)

  • 41. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
    Pezzoli S; Cagnin A; Antonini A; Venneri A
    Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroimaging for Lewy body disease: is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
    Vernon AC; Ballard C; Modo M
    Brain Res Rev; 2010 Oct; 65(1):28-55. PubMed ID: 20685363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    Yong SW; Yoon JK; An YS; Lee PH
    Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies].
    Kasuga K; Ikeuchi T
    Brain Nerve; 2012 May; 64(5):505-13. PubMed ID: 22570064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parkinson's and Lewy body dementia CSF biomarkers.
    Parnetti L; Paciotti S; Farotti L; Bellomo G; Sepe FN; Eusebi P
    Clin Chim Acta; 2019 Aug; 495():318-325. PubMed ID: 31051162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
    Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
    Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
    Taki J; Yoshita M; Yamada M; Tonami N
    Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural and Functional Magnetic Resonance Imaging of Dementia With Lewy Bodies.
    Balážová Z; Nováková M; Minsterová A; Rektorová I
    Int Rev Neurobiol; 2019; 144():95-141. PubMed ID: 30638458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodies.
    Planas-Ballvé A; Rios J; Gea M; Rabaneda-Lombarte N; Ispierto L; Grau L; Jiménez M; Cáceres C; Martínez S; Beyer K; Álvarez R; Pastor P; Vilas D
    Alzheimers Res Ther; 2024 Oct; 16(1):227. PubMed ID: 39407323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weighted network measures reveal differences between dementia types: An EEG study.
    Mehraram R; Kaiser M; Cromarty R; Graziadio S; O'Brien JT; Killen A; Taylor JP; Peraza LR
    Hum Brain Mapp; 2020 Apr; 41(6):1573-1590. PubMed ID: 31816147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lewy body cortical involvement may not always predict dementia in Parkinson's disease.
    Colosimo C; Hughes AJ; Kilford L; Lees AJ
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):852-6. PubMed ID: 12810766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.
    Fritz NE; Kegelmeyer DA; Kloos AD; Linder S; Park A; Kataki M; Adeli A; Agrawal P; Scharre DW; Kostyk SK
    Gait Posture; 2016 Oct; 50():1-7. PubMed ID: 27544062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
    Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
    Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.